Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10312 |
| Vaccine Name | RV3-BB |
| Disease Name | Rotavirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Rotavirus |
| Nucleic Acid Content | double stranded RNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Phase 2 |
| Manufacturer | PT Biofarma |
| Year of Manufacturing | NA |
| Manufacturing Country | Indonesia |
| Age | 0 - 5 days |
| Dosage | 3 doses regimen child schedule (0 to 5 days, 8 weeks, and 14 weeks of age or an infant schedule (8 weeks, 14 weeks, and 18 weeks of age) |
| Administration Route | Oral |
| Adjuvant | NA |
| Target Strain | Three VP8 subunit proteins expressing P[4], P[6] and P[8] serotypes |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://preventrotavirus.org/wp-content/uploads/2019/05/ROTA-Brief2-ProductLandscape-SP-1-3.pdf |
| Additional Links | NA |